Gene Query: UQCC1

Dataset Description Geneva Score
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 19.1
Patient-derived luminal breast cancer xenografts with progestins 18.24
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 18.24
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 17.91
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 17.52
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 17.34
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 15.48
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 14.55
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 14.43
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 14.37
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 14.21
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 13.71
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 13.71
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 13.11
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 12.97
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 12.84
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 12.74
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 12.46
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 12.21
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 11.95
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.45
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 11.18
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 10.88
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.79
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 10.7
Maturation of human iNSCs 10.69
FOXP1 orchestration of ASD-relevant signaling pathways. 10.62
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 10.38
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 10.28
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 10.28
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 10.15
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 10.02
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 9.88
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 9.88
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.79
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 9.68
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 9.65
Androgen Receptor-regulated genes in prostate cancer cells 9.65
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 9.5
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 9.47
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 9.46
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 9.12
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.11
ARS2 is a general suppressor of pervasive transcription [RNAseq] 9.03
Genetic-to-epigenetic Therapy for Pancreatic Cancer 9.01
8.99
Identifying the molecular mode of action of itraconazole in colorectal cancer 8.82
METTL3 promotes translation in human cancer cells 8.76
RNA-seq of cells with TET1 knockout 8.71
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.64
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.4
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.34
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 8.3
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 8.26
Disruption of the exocyst induces podocyte loss and dysfunction 8.23
CD73 knockdown effect in pancreatic cancer cell lines 8.17
A prostate cancer chromatin interaction map 8.07
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 7.99
Gene expression analysis of immortalized human liver progenitor-like cells in culture 7.87
SUV420H2 knockdown in PANC-1 7.87
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 7.76
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 7.76
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.68
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.57
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 7.53
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.46
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 7.33
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.3
The role of FAM46C in myeloma cells 7.05
The role of FAM46C in myeloma cells [sequencing] 7.05
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 7.01
Genome-wide transcriptional response to random aneuploidy in human cells 6.99
Effect of disulfiram treatment on pediatric high grade glioma 6.97
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.87
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 6.86
RNA-seq of IL-4 stimulated human keratinocytes 6.8
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.8
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.79
Effect of PRDM11 depletion in U2932 cells 6.73
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 6.56
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 6.42
Genome wide expression change by RNF168 knocking down in MCF-7 cells 6.41
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 6.41
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 6.39
A sister of NANOG regulates genes expressed in pre-implantation human development 6.35
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 6.35
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 6.35
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.3
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.3
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.28
Transcriptional profiling of LS1034 cells treated with tepoxalin 6.21
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.19
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 6.15
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 6.15
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 6.12
SF3B1 Degron knockdown RNA-seq 6.1
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 6.1
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 6.08
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.07
RNA-sequencing 6.03
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.03
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 6.03
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 6.0
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 5.96
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.93
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.93
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.89
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.89
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.89
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.83
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.79
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 5.79
ChIP-seq and RNA-seq from human lymphoma cell lines 5.78
RNA-seq data from human lymphoma cell lines 5.78
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 5.74
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 5.73
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 5.72
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 5.72
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.68
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 5.67
Lysine benzoylation is a novel histone mark 5.67
Lysine benzoylation is a novel histone mark [RNA-seq] 5.67
H1609088 Human RNA-Sequencing 5.58
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 5.56
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 5.52
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 5.52
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.52
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 5.51
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.48
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.48
Differentially expressed genes post knock down of lincDUSP26 5.44
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.43
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.43
RNA sequencing of human mammary epithelial cells 5.42
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 5.42
RNA-seq in HepG2 and IMR90 cells 5.41
Evolution of a transcriptional regulator from a transmembrane nucleoporin 5.41
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.38
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 5.37
Neurofibroma 5.31
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 5.31
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.28
MYC dependent mRNA translation shapes gene expression and cell biology 5.25
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 5.19
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 5.17
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 5.14
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 5.12
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 5.12
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 5.11
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 5.11
The evolution of N6-methyladenosine in primates 5.05
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 5.05
hTERT promotes cell adhesion and migration independent of telomerase activity 5.02
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 5.01
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 5.01
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.99
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.99
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 4.99
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 4.97
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 4.97
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.97
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.96
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.96
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 4.94
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 4.94
RNAseq Study in CC-671 Treated Cal-51 Cells 4.91
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.89
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.89
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.89
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.87
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.82
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.81
Crizotinib v. DMSO in SW480 cells 4.81
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 4.81
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 4.81
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.75
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.73
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.73
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 4.69
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 4.66
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.61
Transcriptomic analyssis following EHMT1/2 inhibition 4.6
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.53
PNET animal model: new insights (II) 4.52
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.51
DART-seq: an antibody-free method for global m6A detection 4.51
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.5
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 4.48
Effect of mitochondria deficiency on senescence-associated gene expression 4.45
Genome-wide analysis of the Integrator complex 4.41
Genome-wide analysis of the Integrator complex (HTS) 4.41
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 4.4
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 4.4
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 4.36
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.36
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.35
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.29
AUF-1 affected genes in human skin cells 4.29
Differetially expressed genes after hTR overexpression in U2OS cells 4.26
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.2
Aneuploidy triggers an immune response 4.17
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.14
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.12
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.12
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.09
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 4.09
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 4.09
Nucleoporin-mediated regulation of cell identity genes 4.09
Lipid degradation promotes prostate cancer cell survival 4.06
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.05
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.04
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.02
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.01
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.01
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.0
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.0
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.0
KLF6-dependent transcription in renal cancer cells 3.99
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 3.98
Inhibition of TNBC metastasis by Gpx1 3.97
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.97
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 3.97
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.97
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 3.96
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.93
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 3.93
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.93
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.91
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 3.9
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.85
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.85
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.84
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.84
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.83
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.82
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.82
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.81
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 3.78
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.76
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.76
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.76
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 3.76
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 3.76
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 3.73
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 3.72
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 3.72
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.71
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 3.71
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.7
RNA-seq analysis to identify the genes regulated by p53-SET interplay 3.68
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 3.67
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 3.67
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.66
An optimization system for isolating and sequencing of single human colon cancer cells 3.66
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 3.65
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.62
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.62
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.61
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 3.61
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 3.6
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 3.6
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.59
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.56
MeRIP-seq for heat shock in B-cell lymphoma cells 3.56
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 3.56
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.54
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.52
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.52
WRN knockout effects upon gene expression in SW48 and OVK18 3.51
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 3.5
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.48
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 3.47
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 3.47
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.46
Reassessment of Exosome Composition 3.45
Proteomics identifies a marker signature of MAPKi resistance in melanoma 3.44
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.44
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 3.39
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 3.37
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.37
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.34
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 3.33
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.33
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.32
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.31
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.3
Human Treg NaCl stimulation 3.29
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 3.29
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.28
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.22
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.2
Single-cell analysis of adult human ovary using 10X genomics 3.19
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.18
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.18
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 3.14
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.11
Functional role of CPPED1 in trophoblasts. 3.11
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.11
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.09
Patient-derived xenograft platform for metastatic melanoma 3.08
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 3.08
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.07
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 2.99
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 2.97
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 2.97
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.94
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.94
Gene expression in GBM with Cav3.2 inhibition 2.91
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.88
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.87
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.78
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.77
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 2.77
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.76
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.69
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.69
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.67
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.67
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.66
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.65
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.65
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.65
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.61
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 2.6
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.6
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.58
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.57
RNA seq comparison between scrambled and shGRP78 cells 2.57
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.57
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.55
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.52
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.52
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.43
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 2.43
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.4
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.4
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.36
CD74 role in transcription regulation [RNA-seq] 2.36
CD74 role in transcription regulation 2.36
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.33
RNA-seq of cancer cell lines treated with T-025 2.33
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.32
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.31
Ribosome profiling upon inhibition of eIF4A 2.3
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.28
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.22
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.2
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.17
Gene expression profile in breast cancer cells 2.17
DRB/GRO-Seq -/+ UV 2.16
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 2.12
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 2.12
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.1
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.1
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.08
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.07
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.07
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.05
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.04
Activity-dependent transcriptional changes in human neurons 1.99
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.98
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.95
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.93
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.92
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.88
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.88
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.86
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.83
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.8
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.79
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.77
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.75
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 1.72
The bromodomain protein BRD4 regulates splicing during heat shock 1.7
HBEC-shp53-PCHD7 1.68
UV_24h_GRO-Seq 1.62
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.62
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.6
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.57
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.55
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.55
Functional significance of the HIV-1 Tat signature amino acid residues 1.53
Targeted enhancer activation by a subunit of the integrator complex 1.53
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.52
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.51
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.45
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.43
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.43
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.43
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.42
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.38
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.34
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.34
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.33
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.31
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.28
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.26
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.26
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.26
High-throughput sequencing of pluripotent cells 1.24
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.24
Universal alternative splicing of noncoding exons 1.23
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.21
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.19
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.19
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.18
BET bromodomain inhibition 1.18
RNA-seq analysis of breast cancer 1.18
RNA-seq analysis and shRNA screen of breast cancer 1.18
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.18
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.14
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.13
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.11
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.1
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.1
RNA Sequencing of Human iPS derived Cardiomyocytes 1.08
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.08
m6A-dependent regulation of messenger RNA stability 1.06
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 1.06
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.94
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.94
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.92
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.92
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.91
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.87
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.87
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.85
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.78
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.74
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.74
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.74
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.73
K562 polyA RNA-Seq 0.73
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.72
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.7
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.7
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 0.7
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.68
MicroRNA-125a-5p overexpression in human macrophages 0.68
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.68
siRNA-mediated knockdown 0.67
Dilated cardiomyopathy vs Myocarditis 0.67
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.66
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 0.66
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.65
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.65
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.64
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.64
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.64
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.62
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.6
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.6
Regulation of hypoxia-inducible factor activity by ZMYND8 0.6
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.6
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.59
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.59
Modeling Human Cancer-induced Cachexia (Human) 0.58
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.58
Myc activation coordinates gene transcription and protein translation responses 0.55
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.52
Fusion discovery in breast cancer cell line 0.51
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.49
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.49
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.47
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.45
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.44
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.37
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.36
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.3
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.28
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.26
O-glcnAc reprograms cellular energetics 0.23
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.2
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.2
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.2
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.18
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.17
MAIT cell RNA sequencing 0.15
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.14
Function and hormonal regulation of GATA3 in human first trimester placentation 0.14
Epigenomic conservation of transposable element silencing 0.14
Epigenomic conservation of transposable element silencing [RNA-seq] 0.14
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.12
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.12
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.12
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.09
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.09
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.08
Oncogenic roles of ARID5B in T-ALL 0.08
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.08
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.05
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.05
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.05
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.05
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.01
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.0
Effect of nuclear IL-33 on gene expression 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation